WinstonWınston
Arcadia Biosciences logo

Arcadia Biosciences

RKDA
11
Agricultural Inputs · Basic Materials
Price
$0.70
-0.02 (-2.73%)
Market Cap
$1.1M
Exchange
NASDAQ Capital Market
Winston Score
11
Winston is worried
Weak fundamentals across most pillars.
Data as of Aug 9, 2026 · filings through Mar 31, 2026

Share count rising — dilution

+157.1% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 532K (2021) → 1.4M (2025)

Arcadia Biosciences is a small agricultural biotechnology company that develops crops with improved traits, like wheat with more fiber or reduced gluten. Its products target food and ingredient companies looking for healthier or more functional crop varieties. The company also sells consumer food products under its own brands, blending biotech development with direct-to-consumer sales.

Arcadia earns revenue through a mix of product sales, licensing its crop trait technology, and selling branded food items. It operates primarily in the United States and is a very small company, with a market cap near zero, meaning it has limited financial resources compared to larger agricultural biotech rivals like Corteva or Bayer. The deeply negative operating margin signals the company spends far more than it earns, and its biggest risk is running out of cash before its crop traits gain meaningful commercial adoption in the food industry.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-8.3% YoY

YoY Growth Rate

Revenue declining

EPS Growth

-268.9% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$9,000/ year

Declining (-83% vs prior year)

0.2% of revenue

Below sector average (3%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

0.0%ownership

Relatively low insider ownership

Cash Runway

~10 months

$4M cash & investments

Quarterly Free Cash Flow

Short runway — potential dilution ahead through share issuance

Cash watch

Arcadia Biosciences has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
36.4%
Modest — 36.4% gross margin
Operating Margin
-70.8%
Losing money on operations — -70.8%
ROCE
-27.0%
Weak — -27.0% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-9.5%
Shrinking sales (-9.5% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
-89.3%
Burning cash (-89.3%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
N/A
Data not available
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial